Get the Stockscreener App
21.55
0.05%
0.01
After Hours:
21.55
Avadel Pharmaceuticals Plc stock is traded at $21.55, with a volume of 396.42K.
It is up +0.05% in the last 24 hours and up +0.28% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$21.54
Open:
$21.56
24h Volume:
396.42K
Relative Volume:
0.14
Market Cap:
$2.11B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
-653.03
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
-0.14%
1M Performance:
+0.28%
6M Performance:
+143.50%
1Y Performance:
+105.04%
1-Day Range:
$21.51
$21.56
1-Week Range:
$21.50
$21.60
52-Week Range:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.55 | 2.11B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Bank of America discloses 2.38% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 2.38% stake in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
REGBlackRock Group Avadel Pharma plcForm 8.3Avadel Pharmaceuticals plc - TradingView — Track All Markets
Geode Capital discloses 2.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley & Co.Rule 38.5_AAvadel Pharmaceuticals plc - Research Tree
Goldman Sachs & Co.38.5b-Avadel Pharmaceuticals PLC - Research Tree
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Sees Large Drop in Short Interest - MarketBeat
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trades in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Precision Trading with Avadel Pharmaceuticals Plc (AVDL) Risk Zones - Stock Traders Daily
Goldman Sachs (EPT)ITP Only(38.5bAvadel Pharmaceuticals PLC) - Research Tree
Bank of America discloses 2.37% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Morgan Stanley discloses trades in Avadel Pharmaceuticals shares - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley Europe SE reports Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.89% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.89% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2.1% stake in Avadel Pharmaceuticals - Investing.com
JP Morgan Sec LLCForm 38.5B(EPT/NON-RI)-Avadel Pharmaceuticals plc - Research Tree
Morgan StanleyEuropeRule 38.5_BAvadel Pharmaceuticals plc - Research Tree
Morgan Stanley Europe SE reports Avadel Pharmaceuticals dealings - Investing.com
Bank of America discloses 2.17% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.09% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
J.P. Morgan discloses trading in Avadel Pharmaceuticals amid takeover By Investing.com - Investing.com Nigeria
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
JPMorgan Sec.PlcForm 38.5a (EPT/RI)-Avadel Pharmaceuticals Amend - Research Tree
J.P. Morgan discloses trading in Avadel Pharmaceuticals amid takeover - Investing.com
Citadel Group discloses 1.09% stake in Avadel Pharmaceuticals - Investing.com
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals - Investing.com India
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.30%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):